tiktok���˰�

Competition Act 1998: Primary UK competition legislation, particularly Chapter I prohibitions on anti-competitive agreements. Critical for reverse payment agreements as they may be scrutinized for potential anti-competitive effects.

Article 101 TFEU: Treaty on the Functioning of the European Union article governing anti-competitive agreements. Remains relevant as persuasive authority post-Brexit.

Enterprise Act 2002: UK legislation providing framework for competition law enforcement and market investigations.

Patents Act 1977: Primary UK patent legislation governing intellectual property rights, essential for understanding the underlying patent disputes in reverse payment agreements.

Trade Marks Act 1994: Legislation governing trademark rights which may be relevant if branded pharmaceuticals are involved in the agreement.

Medicines Act 1968: Fundamental legislation governing the control of medicines in the UK, including licensing and marketing authorization.

Human Medicines Regulations 2012: Current regulatory framework for medicines, including requirements for marketing authorization and distribution.

Patents Regulations 2007: Regulations governing compulsory licensing and supplementary protection certificates, relevant for pharmaceutical patent term extensions.

CMA Guidelines: Competition and Markets Authority guidance on competition law compliance and enforcement, particularly relevant for assessment of reverse payment agreements.

Consumer Rights Act 2015: Legislation protecting consumer interests, relevant for considering public impact of reverse payment agreements.

Unfair Contract Terms Act 1977: Legislation controlling unfair terms in contracts, ensuring balance and fairness in agreement provisions.